Q32 BIO INC
QTTB · NASDAQ
Updated at 2026-10-14 09:06:44
- Today's High
- $8.69
- Today’s Low
- $7.89
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $8.64
- Previous Close
- $8.74
- Volume
- 684.59K
- Market Cap
- $260.18M
- P/E Ratio
- 8.81X
- EPS
- $2.28
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 830 WINTER STREET, WALTHAM, MA, UNITED STATES, 02451
- Country
- US
- Listing Date
- 2018-03-28
- Fiscal Year End
- December
- Shares Outstanding
- 29.76M
- CIK
- 0001661998
- Website
- www.q32bio.com
Q32 Bio Inc. (QTTB) is a pioneering biotechnology firm focused on the development of advanced antibody-based therapies for autoimmune diseases and immune response optimization. Leveraging its proprietary technology platform, the company is building a robust pipeline of therapeutic candidates designed to restore immune balance and tackle significant unmet medical needs. Guided by a seasoned management team and reinforced by strategic collaborations, Q32 Bio is well-positioned to make impactful contributions to healthcare and generate substantial long-term value for its shareholders through dedicated research and development initiatives.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$53.73M
2025-09-30
$0
Operating Expenses
2026-06-30
$9.03M
2026-03-31
$7.72M
2025-12-31
$7.85M
2025-09-30
$7.57M
Net Income
2026-06-30
-$8.94M
2026-03-31
-$7.6M
2025-12-31
$57.73M
2025-09-30
-$7.38M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
107.43%
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.44
2026-03-31
$-0.54
2025-12-31
$4.58
2025-09-30
$-0.60
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$8.86M
2026-03-31
-$7.63M
2025-12-31
$58.02M
2025-09-30
-$6.99M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $53.73M | $0 |
| Operating Expenses | $9.03M | $7.72M | $7.85M | $7.57M |
| Net Income | -$8.94M | -$7.6M | $57.73M | -$7.38M |
| Net Profit Margin | -- | -- | 107.43% | -- |
| Earnings Per Share | $-0.44 | $-0.54 | $4.58 | $-0.60 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$8.86M | -$7.63M | $58.02M | -$6.99M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.